Planet Labs PBC filings document an Earth-observation company that provides satellite imagery, geospatial data, and related software solutions. The company’s 8-K reports include operating results, Regulation FD disclosures, material agreements, and other events tied to its commercial and government satellite-data business.
Recent filings also describe capital-structure matters involving Class A common stock, Class B common stock, earnout share issuances, and public warrants originally issued with IPO units. The record includes warrant redemption disclosures and a Form 25 covering removal of the redeemable warrants from NYSE listing and registration.
Planet Labs PBC CEO, Co-Founder and Director William Spencer Marshall reported a tax-related share withholding tied to restricted stock unit (RSU) vesting. On 12/15/2025, 121,897 shares of Class A Common Stock were withheld by the company at $18.05 per share to satisfy withholding tax liabilities from vested RSUs, and no shares were sold into the market.
After this transaction, Marshall beneficially owns 3,034,490 Class A shares, including 2,069,641 RSUs. These RSUs vest in equal quarterly installments on the 15th of March, June, September and December, with each RSU representing a contingent right to receive one share of Class A Common Stock and having no expiration date.
Planet Labs PBC reported higher revenue but a wider net loss for the quarter ended October 31, 2025. Quarterly revenue rose to $81.3 million from $61.3 million a year earlier, driven by growth across North America, Asia Pacific & Japan, EMEA and Latin America, with Defense & Intelligence customers contributing the largest share. Gross profit increased to $46.6 million, and the operating loss narrowed to $18.3 million from $22.6 million as operating expenses grew more slowly than revenue.
However, a large non-cash charge from the change in fair value of warrant liabilities led to a quarterly net loss of $59.2 million, compared with a $20.1 million loss a year earlier. For the first nine months, revenue reached $220.9 million versus $182.8 million, while the net loss was $94.4 million. Liquidity strengthened, with cash, cash equivalents and short-term investments totaling about $677.3 million and remaining performance obligations of $672.5 million, alongside $446.2 million of convertible notes on the balance sheet.
Planet Labs PBC announced its financial results for the third fiscal quarter ended October 31, 2025. The company also scheduled a conference call and webcast to discuss these results at 5:00 p.m. Eastern time on December 10, 2025. A press release containing the detailed quarterly results is attached as Exhibit 99.1 and incorporated by reference, while the information is furnished rather than filed under securities law, limiting certain legal liabilities.
Driehaus Capital Management LLC filed a Schedule 13G reporting beneficial ownership of 14,372,467 shares of Planet Labs PBC Class A common stock, representing 5.01%, as of 09/30/2025.
Driehaus reports shared voting and dispositive power over 14,372,467 shares and no sole voting or dispositive power. The shares are held on a fully discretionary basis in numerous client accounts. Driehaus certifies the holdings were acquired and are held in the ordinary course and not to change or influence control.
Planet Labs PBC (PL) director Scott Reese reported an equity award. On 11/03/2025, he acquired 8,807 shares of Class A Common Stock at a price of $0, reported as restricted stock units (RSUs) that each represent the right to receive one share.
The RSUs will fully vest on the earlier of the first anniversary of the company’s most recent annual meeting of stockholders or the date of the next annual meeting following the grant, subject to continuous service through the vesting date. Following the transaction, 8,807 shares were shown as directly beneficially owned.
Planet Labs PBC (PL) reported an initial statement of beneficial ownership on Form 3 for director Scott Reese. The filing states that no securities are beneficially owned as of 11/03/2025. A power of attorney (Exhibit 24) authorized the attorney-in-fact to sign on behalf of the reporting person.
Planet Labs PBC (PL) insider trade: Co‑Founder and Chief Strategy Officer Robert H. Schingler, also a Director, reported a sale of 81,656 shares of Class A Common Stock on 10/13/2025 at a weighted average price of $15.4959, executed under a Rule 10b5‑1 trading plan adopted on July 14, 2025. Following the transaction, he beneficially owns 1,288,843 shares, which include 933,672 RSUs that vest in equal quarterly installments on the 15th of March, June, September and December.
Planet Labs PBC (PL) reported an insider transaction by Co-Founder and CEO William Spencer Marshall. On 10/13/2025, he sold 200,000 shares of Class A common stock at a weighted average price of $15.4966, executed under a Rule 10b5-1 trading plan adopted on July 12, 2025. Following the sale, he beneficially owns 3,156,387 shares directly. His holdings include 2,309,686 RSUs that vest in equal quarterly installments on the 15th of March, June, September, and December; each RSU represents a right to receive one share and has no expiration date.
Carl Bass, a director of Planet Labs PBC (PL), exercised stock options and sold shares on 10/06/2025. He exercised 376,748 options with an exercise price of $2.33 per share and simultaneously sold 376,748 Class A shares at a weighted-average price of $15.669 per share. After the transactions, he beneficially owned 317,530 Class A shares. The filing also corrects two previously misreported option expiration dates and shows an additional 153,183 option shares exercisable at an exercise price of $3.92 expiring on 11/06/2029. The transactions were reported on the SEC Form 4 filed for 10/06/2025.
Form 144 notice for Planet Labs PBC (PL) reports a proposed sale of 376,748 common shares by an insider via Morgan Stanley Smith Barney LLC on the NYSE. The filer indicates the shares were acquired and paid for the same day through a stock option exercise on 10/06/2025, and the aggregate market value of the shares at the time of the notice is $5,903,264.41. The filer certifies no undisclosed material adverse information is known and reports no other sales in the prior three months. The notice specifies cash payment for the exercised shares and lists the broker's address.